Mei Ri Jing Ji Xin Wen·2025-07-03 08:54Core Viewpoint - Tianqi Materials (SZ002709) is involved in a commercial secret infringement dispute, filing a civil lawsuit against multiple parties, including Yongtai Technology (SZ002326) and its subsidiary, for economic damages of 887 million yuan [1][3]. Group 1: Legal Proceedings - Tianqi Materials announced that its wholly-owned subsidiary, Jiujiang Tianqi High-tech Materials Co., Ltd. (Jiujiang Tianqi), has filed a lawsuit with the Jiangxi Provincial High Court against 12 defendants, including Li Sheng and Shaowu Yongtai High-tech Materials Co., Ltd. [1] - The lawsuit stems from allegations that former employee Li Sheng leaked technical information to Shaowu Yongtai, which has been used in their production of liquid lithium salts [2][3]. - The lawsuit requests the defendants to cease infringing on Tianqi's technical secrets, destroy production line equipment, and collectively compensate for economic losses amounting to 887 million yuan [3]. Group 2: Company Statements - Tianqi Materials believes that the defendants have shown clear intent to infringe, with significant scale and benefits from the infringement [3]. - The company stated that the ongoing legal proceedings are not expected to have a direct negative impact on its current financial results, but the potential effects on future profits remain uncertain [3]. - Tianqi emphasized the uniqueness of its liquid lithium hexafluorophosphate technology and mentioned that it is gathering evidence for additional parties to be sued [3]. Group 3: Yongtai Technology's Response - Yongtai Technology acknowledged the lawsuit but stated that it has not received any legal documents related to the case [4]. - The company asserted its commitment to respecting intellectual property rights and emphasized that its production processes are based on completely independent intellectual property [4]. - Yongtai clarified that it currently only produces solid lithium hexafluorophosphate and has not engaged in the production or sale of the liquid variant involved in the lawsuit [4].